Alto Capital's Tony Locantro tells Proactive's Andrew Scott he's maintaining large positions in his favourite biotech firms including Exopharm (ASX:EX1) and Nyrada Inc (ASX:NYR). He adds that he's been picking up Godolphin Resources (ASX:GRL) as well as Aurumin (ASX:AUN).
28 Jan 21